A Patient with Ovarian Cancer Weathers the COVID-19 Storm at Her Local Health Center

Video

The COVID-19 pandemic has changed how people receive health care services. For Donna Wiegle, director of the Mill Pond Health Center in Maine, and cervical cancer survivor and patient with ovarian cancer, the pandemic hasn’t yet changed how her island’s health center provides residents with routine care.

The approximately 350 year-round residents of Swan’s Island, a small island near Acadia National Park off the coast of Maine, have received routine medical care from the Mill Pond Health Center for the last 13 years. And although the new coronavirus pandemic, also known as COVID-19, has altered how people receive health care everywhere, the health center’s director — a patient with cancer herself – tells CURE® that it will stay open and continue to provide care for as long as it can.

CURE® spoke with Donna Wiegle, a survivor of cervical cancer who is currently battling ovarian cancer, about her cancer journey as well as the precautions the center is taking to ensure the safety of its patients. Additionally, Wiegle offers insight into why, even as she may be at more risk for the virus as a patient with cancer, she has not decided to close the island’s only health center.

“I've given this a lot of thought about my own risk to stay working, because this is entirely my decision,” she said. “I recognize that we need health services that other communities have readily available to them. What we have is very minimal to begin with … (and) I feel that my community has come to depend on me over all these years and I don't want to let them down.”

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE